Patents by Inventor Steven John PADULA

Steven John PADULA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20240018232
    Abstract: The present invention relates to the treatment of inflammatory bowel disease (IBD) with anti-IL36R antibodies.
    Type: Application
    Filed: August 2, 2023
    Publication date: January 18, 2024
    Inventors: Wulf Otto BOECHER, Janine LAMAR, Steven John PADULA
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20230131364
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: August 10, 2022
    Publication date: April 27, 2023
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20230115617
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: November 10, 2022
    Publication date: April 13, 2023
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • ANTI IL-36R ANTIBODIES COMBINATION THERAPY
    Publication number: 20230044739
    Abstract: The present invention relates to anti-IL-36R binding compounds, in particular new anti-IL-36R antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: September 7, 2022
    Publication date: February 9, 2023
    Inventors: Wulf Otto BOECHER, Steven John PADULA, Christian THOMA
  • ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF NEUTROPHILIC DERMATOSES
    Publication number: 20220073628
    Abstract: The present invention provides methods for treating, preventing or ameliorating a neutrophilic dermatosis. The methods of the present invention include administering to a patient suffering from a neutrophilic dermatosis a pharmaceutical composition including an anti-interleukin-36 receptor (anit-IL-36R) antibody.
    Type: Application
    Filed: July 15, 2021
    Publication date: March 10, 2022
    Inventors: Jay FINE, Janine LAMAR, Steven John PADULA, Meera RAMANUJAM, Sudha VISVANATHAN
  • ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS
    Publication number: 20220010022
    Abstract: The present invention provides methods for treating, preventing or ameliorating atopic dermatitis (AtD). In certain embodiments, the invention provides methods to reduce skin infection in a patient with atopic dermatitis. The methods of the present invention include administering to a patient in need thereof a pharmaceutical composition including an anti-interleukin-36 receptor (anit-IL-36R) antibody.
    Type: Application
    Filed: May 17, 2021
    Publication date: January 13, 2022
    Inventors: Mary Ruth FLACK, Jay FINE, Janine LAMAR, Steven John PADULA, Chandrasena Reddy PAMULAPATI, Meera RAMANUJAM, Ralf SIGMUND, Sudha VISVANATHAN, Elizabeta ZOVKO
  • ANTI-IL-23 ANTIBODIES
    Publication number: 20210317201
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 14, 2021
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG
  • Anti-IL-23 antibodies
    Patent number: 11078265
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: August 3, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry Nabozny, Annette Bettina Galler, Patrick Garidel, William Troy Loging, Steven John Padula, Torsten Schultz-Fademrecht, Elaine Ee-Ling Wang
  • USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF GENERALIZED PUSTULAR PSORIASIS
    Publication number: 20210087285
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of an acute phase flare-up of generalized pustular psoriasis (GPP) with anti-IL36R antibodies.
    Type: Application
    Filed: November 23, 2020
    Publication date: March 25, 2021
    Inventors: Christian THOMA, Steven John PADULA, Janine LAMAR
  • USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20210061901
    Abstract: The present invention relates to the treatment of inflammatory bowel disease (IBD) with anti-IL36R antibodies.
    Type: Application
    Filed: November 12, 2020
    Publication date: March 4, 2021
    Inventors: Wulf Otto BOECHER, Janine LAMAR, Steven John PADULA
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20200308271
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 21, 2019
    Publication date: October 1, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth Flack, Annette Bettina Galler, Bojan Lalovic, Kaori Maino, Steven John Padula, Paul Scholl, Koji Sha, Sudha Visvanathan
  • ANTI-IL-36R ANTIBODIES FOR TREATMENT OF PALMOPLANTAR PUSTULOSIS
    Publication number: 20200207862
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of palmoplantar pustulosis (PPP) with anti-IL-36R antibodies in a patient.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 2, 2020
    Inventors: Patrick BAUM, Janine LAMAR, Steven John PADULA, Christian THOMA
  • USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE
    Publication number: 20190284273
    Abstract: The present invention relates to the treatment of inflammatory bowel disease (IBD) with anti-IL36R antibodies.
    Type: Application
    Filed: March 8, 2019
    Publication date: September 19, 2019
    Inventors: Wulf Otto BOECHER, Janine LAMAR, Steven John PADULA
  • USE OF ANTI-IL-36R ANTIBODIES FOR TREATMENT OF GENERALIZED PUSTULAR PSORIASIS
    Publication number: 20190284285
    Abstract: The present invention relates to the treatment of or alleviation of signs and symptoms of an acute phase flare-up of generalized pustular psoriasis (GPP) with anti-IL36R antibodies.
    Type: Application
    Filed: March 8, 2019
    Publication date: September 19, 2019
    Inventors: Christian Thoma, Steven John Padula, Janine Lamar
  • ANTI IL-36R ANTIBODIES COMBINATION THERAPY
    Publication number: 20180273627
    Abstract: The present invention relates to anti-IL-36R binding compounds, in particular new anti-IL-36R antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: March 26, 2018
    Publication date: September 27, 2018
    Inventors: Wulf Otto BOECHER, Steven John PADULA, Christian THOMA
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20170298126
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Kaori MAINO, Steven John PADULA, Paul SCHOLL, Koji SHA, Sudha VISVANATHAN
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20170081402
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 23, 2017
    Inventors: Wulf Otto BOECHER, Annette Bettina GALLER, Bojan LALOVIC, Steven John PADULA, Paul SCHOLL, Sudha VISVANATHAN
  • METHODS OF TREATING INFLAMMATORY DISEASES
    Publication number: 20160222102
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis, psoriatic arthritis or axial (spinal) spondyloarthritis (ax-SpA), including ankylosing spondylitis and non-radiographic ax-SpA, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: February 2, 2016
    Publication date: August 4, 2016
    Inventors: Matthias ARNDT, Stella ASLANYAN, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Steven John PADULA, Paul Russell SCHOLL
  • ANTI-IL-23 ANTIBODIES
    Publication number: 20140178401
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 26, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG